Maitotoxin-induced nerve growth factor production accompanied by the activation of a voltage-insensitive Ca2+ channel in C6-BU-1 glioma cells

British Journal of Pharmacology

Volumn 127, Issue 7, 1999, Pages 1577-1582

  Obara, Yutaro ^a   Takahashi, Masami ^b   Nakahata, Norimichi ^a   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

Author keywords

Calcium channel; Calcium influx; Maitotoxin; Nerve growth factor (NGF); NGF mRNA; Rat glioma cell (C6 BU 1)

Indexed keywords

BUCLADESINE; CALCIMYCIN; CALCIUM CHANNEL; CALCIUM ION; MAITOTOXIN; MESSENGER RNA; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXTRACELLULAR CALCIUM; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0032785250     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702706     Document Type: Article

References (39)

1. AMAND, D., POTTAGE, C., HENRY, P. & FAHNESTOCK, M. (1996). Method for quantitation of low-abundance nerve growth factor mRNA expression in human nervous tissue using competitive reverse transcription polymerase chain reaction. DNA Cell Biol., 15, 415-422.
2. AMANO, T., YAMAKUNI, T., OKABE, N., KUWAHARA, R., OZAWA, F. & HISHINUMA, F. (1992). Regulation of nerve growth factor and nerve growth factor receptor production by NMDA in C6 glioma cells. Mol. Brain Res., 14, 35-42.
3. BENDA, P., LIGHTBODY, J., SATO, G., LEVINE, L. & SWEET, W. (1968). Differentiated rat glial cell strain in tissue culture. Science, 161, 370-371.
4. BIELFELDACKERMANN, A., RANGE, C. & KORMACHER, C. (1998). Maitotoxin (MTX) activates a nonselective cation channel in xenopus laevis oocytes. Pflugers Arch. Eur. J. Physiol., 436, 329-337.
5. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 73, 248-254.
6. CAMPBELL, A.K. (1983). Intracellular Calcium, its Universal Role as Regulator. Chichester: John Wiley & Sons Ltd.
7. CARMAN-KRZAN, M. & WISE, B.C. (1993). Arachidonic acid lipoxygenation may mediate interleukin-1 stimulation of nerve growth factor secretion in astroglial cultures. J. Neurosci. Res., 34, 225-232.
8. NGF binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. Mol. Brain Res., 35, 1-10.
9. 2+ entry in MDCK renal epithelial cells. Mol. Pharmacol., 45, 300-305.
10. D'MELLO, S.R. & HEINRICH, G. (1991). Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promoter. Mol. Brain Res., 11, 225-264.
11. ESTACION, M., NGUYEN, H.B. & GARGUS, J.J. (1996). Calcium is permeable through a maitotoxin-activated nonselective cation channel in mouse L cells. Am. J. Physiol., 270, C1145-C1152.
12. FLECKENSTEIN A. (1971). In Calcium and Heart eds. Harris, P. & Opie, L.H., pp. 135-188. London: Academic Press.
13. FUKUMOTO, H., KAKIHANA, M. & SUNO, M. (1994). Characterization of C6-10A glioma cells highly responsive to β-adrenergic receptor agonist-induced NGF synthesis/secretion. Glia, 12, 151-160.
14. GALVE-ROPERH, I., HARO, A. & DIAZ-LAVIADA, I. (1997). Induction of nerve growth factor synthesis by sphingomyelinase and ceramide in primary astrocyte cultures. Mol. Brain Res., 52, 90-97.
15. GUSOVSKY, F. & DALY, J.W. (1990). Maitotoxin: a unique pharmacological tool for research on calcium-dependent mechanisms. Biochem. Pharmacol., 39, 1633-1639.
16. HAGIWARA, M., BRINDLE, P., HAROOTUNIAN, A., ARMSTRONG, R., RIVER, J., VALE, W., TSIEN, R. & MONTMINY, M.R. (1993). Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol. Cell Biol., 13, 4852-4859.
17. HANNUN, Y.A. (1996). Functions of ceramide in coordinating cellular responses to stress. Science, 274, 1855-1859.
18. HEESE, K., FIEBICH, B.L., BAUER, J. & OTTEN, U. (1998). NF-κB modulates lipopolysaccharide-induced microglial nerve growth factor expression. Glia, 22, 401-407.
19. 12. Prostaglandins and other lipid mediators, 55, 159-168.
20. 2+ and isoproterenol. Mol. Cell. Biol., 14, 8272-8281.
21. JEHAN, F., NEVEU, I., PHILIPPE, N., NAVEIHAN, P., WION, D. & BRACHET, P. (1995). Interactions between second messenger pathways influence NGF synthesis in mouse primary astrocytes. Brain Res., 672, 128-136.
22. KALTSCHMIDT, C., KALTSCHMIDT, B., LANNES-VIEIRA, J., KREUTZBERG, G.W., WEKERLE, H., BAEUERLE, P.A. & GEHRMANN, J. (1994). Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyclitis. J. Neuroimmunol., 55, 99-106.
23. 2+ influx in rat glioma C6 cells by brevetoxins and synthetic fragments of maitotoxin, J. Neurochem., 70, 409-416.
24. LEECII, C.A. & HABENER, J.F. (1997). Insulinotropic glucagon-like peptide-1-mediated activation of non-selective cation currents in insulinoma cells is mimicked by maitotoxin. J. Biol. Chem., 272, 17987-17993.
25. LEVI-MONTALCINI, R. (1987). The nerve growth factor 35 years later. Science, 237, 1154-1162.
26. LIN, L.H., DOHERTY, D.H., LILE, J.D., BEKTESH, S. & COLLINS, F. (1993). GDNF: A Glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
27. MOCCHETTI, I., DE BERNARDI, M.A., SZEKELY, A.M., ALHO, H., BROOKER, G. & COSTA, E. (1989). Regulation of nerve growth factor biosynthesis by β-adrenergic receptor activation in astrocytoma cells: A potential role of c-Fos protein. Proc. Natl. Acad. Sci. U.S.A., 86, 3891-3895.
28. 2+ flux in cells by maitotoxin. Eur. J. Pharmacol., 227, 43-49.
29. NEVEU, I., JEHAN, F., HOULGATTE, R., WION, D. & BRACHET, P. (1992). Activation of nerve growth factor synthesis in primary glial cells by phorbol 12-myristate 13-acetate: role of protein kinase C. Brain Res., 570, 316-322.
30. OHIZUMI, Y. (1997). Application of physiologically active substances isolated from natural resources to pharmacological studies. Jpn. J. Pharmacol., 73, 263-289.
31. 2+ pathway in rabbit platelets. Br. J. Pharmacol., 117, 1095-1104.
32. 3-induced HL-60 cell differentiation. J. Biol. Chem., 269, 4070-4077.
33. O'NEILL, L.A.J. & KALTSCHMIDT, K. (1997). NF-κB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci., 20, 252-258.
34. RUDGE, J.S., PANSNIKOWSKI, E.M., HOLST, P. & LINDSAY, R.M. (1995). Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid. J. Neurosci., 15, 6856-6867.
35. 2--ATPase inhibitor thapsigargin. Proc. Natl. Acad. Sci. U.S.A., 88, 7096-7100.
36. SCHWARTZ, J.P. (1988). Stimulation of nerve growth factor mRNA content in C6 glioma cells by a β-adrenergie receptor and by cyclic AMP. Glia, 1, 282-285.
37. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science, 252, 1427-1430.
38. TAGLIALATELA, G., ROBINSON, R. & PEREZ-POLO, JR. (1997). Inhibition of nuclear factor kappa B (NFκB) activity induces nerve growth factor-resistant apoptosis in PC12. J. Neurosci. Res., 47, 155-162.
39. WONG, W.L., BROSTROM, M.A., KUZNETSOV, G., GMlTTER-YELLEN, D. & BROSTROM, C.O. (1993). Inhibition of protein synthesis and early protein processing by thapsigargin in cultured cells. Biochem. J., 289, 71-79.